PIC Therapeutics Completes $35 Million Financing To Develop Treatments for Drug-Resistant Breast Cancer
editor In full transparency, the following is a press release submitted to SOURCE media through its business wire service. *** NATICK – PIC Therapeutics, Inc., a biopharmaceutical company dedicated to developing…